121 related articles for article (PubMed ID: 33440048)
1. Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study.
Choi YM; Hwang KR; Oh SH; Lee D; Chae SJ; Yoon SH; Kim JJ
Clin Endocrinol (Oxf); 2021 May; 94(5):837-844. PubMed ID: 33440048
[TBL] [Abstract][Full Text] [Related]
2. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
[TBL] [Abstract][Full Text] [Related]
3. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.
Capula C; Chiefari E; Vero A; Foti DP; Brunetti A; Vero R
Diabetes Res Clin Pract; 2014 Aug; 105(2):223-30. PubMed ID: 24931701
[TBL] [Abstract][Full Text] [Related]
5. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
[TBL] [Abstract][Full Text] [Related]
6. Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome.
Dargham SR; Shewehy AE; Dakroury Y; Kilpatrick ES; Atkin SL
Sci Rep; 2018 Feb; 8(1):3619. PubMed ID: 29483674
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.
Kazemi Jaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Hosseinpanah F; Khalili D; Cheraghi L; Azizi F
Fertil Steril; 2017 Dec; 108(6):1078-1084. PubMed ID: 29202960
[TBL] [Abstract][Full Text] [Related]
8. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
Carlsson LMS; Sjöholm K; Karlsson C; Jacobson P; Andersson-Assarsson JC; Svensson PA; Larsson I; Hjorth S; Neovius M; Taube M; Carlsson B; Peltonen M
Lancet Diabetes Endocrinol; 2017 Apr; 5(4):271-279. PubMed ID: 28237791
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome.
Seneviratne HR; Lankeshwara D; Wijeratne S; Somasunderam N; Athukorale D
BJOG; 2009 Dec; 116(13):1722-8. PubMed ID: 19775306
[TBL] [Abstract][Full Text] [Related]
10. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.
Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H
Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.
Lazaridou S; Dinas K; Tziomalos K
Hormones (Athens); 2017 Oct; 16(4):373-380. PubMed ID: 29518757
[TBL] [Abstract][Full Text] [Related]
12. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.
Li HW; Lam KS; Tam S; Lee VC; Yeung TW; Cheung PT; Yeung WS; Ho PC; Ng EH
Hum Reprod; 2015 Sep; 30(9):2178-83. PubMed ID: 26202923
[TBL] [Abstract][Full Text] [Related]
13. The role of glycated hemoglobin in the diagnosis of prediabetes and diabetes mellitus in young women with polycystic ovary syndrome.
Melo RH; Pontes AG; Delmanto LRMG; Bueloni-Dias FN; Vespoli HL; Nahas EAP
Clin Endocrinol (Oxf); 2024 Feb; 100(2):124-131. PubMed ID: 37828797
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis.
Belsti Y; Enticott J; Azumah R; Tay CT; Moran L; Ma RCW; Joham AE; Laven J; Teede H; Mousa A
Diabetes Metab Syndr; 2024 Mar; 18(3):102970. PubMed ID: 38442646
[TBL] [Abstract][Full Text] [Related]
15. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
16. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
Koivula RW; Forgie IM; Kurbasic A; Viñuela A; Heggie A; Giordano GN; Hansen TH; Hudson M; Koopman ADM; Rutters F; Siloaho M; Allin KH; Brage S; Brorsson CA; Dawed AY; De Masi F; Groves CJ; Kokkola T; Mahajan A; Perry MH; Rauh SP; Ridderstråle M; Teare HJA; Thomas EL; Tura A; Vestergaard H; White T; Adamski J; Bell JD; Beulens JW; Brunak S; Dermitzakis ET; Froguel P; Frost G; Gupta R; Hansen T; Hattersley A; Jablonka B; Kaye J; Laakso M; McDonald TJ; Pedersen O; Schwenk JM; Pavo I; Mari A; McCarthy MI; Ruetten H; Walker M; Pearson E; Franks PW;
Diabetologia; 2019 Sep; 62(9):1601-1615. PubMed ID: 31203377
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
Tomlinson J; Millward A; Stenhouse E; Pinkney J
Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
[TBL] [Abstract][Full Text] [Related]
18. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.
Veltman-Verhulst SM; Goverde AJ; van Haeften TW; Fauser BC
Hum Reprod; 2013 Aug; 28(8):2228-34. PubMed ID: 23739218
[TBL] [Abstract][Full Text] [Related]
19. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.
Norman RJ; Masters L; Milner CR; Wang JX; Davies MJ
Hum Reprod; 2001 Sep; 16(9):1995-8. PubMed ID: 11527911
[TBL] [Abstract][Full Text] [Related]
20. Frequency of prediabetes in women with polycystic ovary syndrome.
Ibricevic D; Asimi ZV
Med Arch; 2013; 67(4):282-5. PubMed ID: 24520755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
